Inotiv

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

HLIT

NOTV


Market signals are tough to follow because they often fail to deliver their promises. For example, despite their insider activity, the three stocks on this list are all quality buys. In two cases, the insiders are

2 Stocks Insiders Are Buying and 1 They&#39;re Selling

Image32

Earnings

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

AUGX

BABA

CTNT

SCPX

SPWR

Nasdaq Rises 100 Points; Alibaba Posts Weak Earnings

alibaba_logo

Movers

AGYS

AKYA

BETR

BIOL

BYND

CLOV

DCTH

DWSN

EAST

FENC

FFIE

FOSL

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HROW

INVO

JAMF

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MBIN

NOVA

ONON

PLUG

PSFE

RENT

SHIM

SMRT

Sony Group Corporation American Depositary Shares

SONY

SPCE

STNE

SYRA

TLRY

UXIN

VUZI

WOOF

WULF

Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Inotiv Inc

Press Releases

Inotiv, Inc. to Participate in Upcoming Jefferies and Craig-Hallum Investor Conferences

Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024

Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update

Financing

Inotiv, Inc. Launches Proposed Public Offering of Common Shares

Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares

Health Care

Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million

Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million

Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025

Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update

Akoya Biosciences

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences

Atlantic International Corp. - Common Stock

Atlantic International

Bionano Genomics

Conduit Pharmaceuticals Inc. - Common Stock

Conduit Pharmaceuticals

Codexis

Champions Oncology

Harvard Bioscience

Lifecore Biomedical

MaxCyte

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

OmniAb

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

Lake Street

Craig-Hallum

Jefferies

Wells Fargo

Comments

Inotiv

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga